Company Overview of Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc., a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its TRN-157 is a preclinical development program that focuses on the treatment of chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.
365 San Aleso Avenue
Sunnyvale, CA 94085
Founded in 2008
Key Executives for Theron Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Denali Therapeutics Inc.||United States|
|Triton Algae Innovations Ltd.||United States|
|Aursos, Inc.||United States|
|Agilis Biotherapeutics, LLC||United States|
|Novactyl, Inc.||United States|
Recent Private Companies Transactions
July 24, 2015
To contact Theron Pharmaceuticals, Inc., please visit www.theronpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.